Copyright
©The Author(s) 2022.
World J Clin Oncol. Oct 24, 2022; 13(10): 813-821
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.813
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.813
Table 1 Absolute frequencies and percentages of patients with and without severe oral mucositis by follow-up week
Week | Dentoxol® (n = 55) | Control (n = 53) | |||||||
No severe oral mucositis | Severe oral mucositis | No severe oral mucositis | Severe oral mucositis | P value | |||||
n | % | n | % | n | % | n | % | ||
1 | 49 | 94.2 | 3 | 5.8 | 49 | 98.0 | 1 | 2.0 | 0.327 |
2 | 49 | 100 | 0 | 0.0 | 42 | 95.5 | 2 | 4.5 | 0.131 |
3 | 47 | 95.9 | 2 | 4.1 | 30 | 76.9 | 9 | 23.1 | 0.007a |
4 | 42 | 91.3 | 4 | 8.7 | 29 | 70.7 | 12 | 29.3 | 0.013a |
5 | 33 | 73.3 | 12 | 26.7 | 19 | 52.8 | 17 | 47.2 | 0.055 |
6 | 29 | 64.4 | 16 | 35.6 | 15 | 46.9 | 17 | 53.1 | 0.125 |
7 | 22 | 57.9 | 16 | 42.1 | 11 | 44.0 | 14 | 56.0 | 0.280 |
8 | 11 | 57.7 | 6 | 35.3 | 4 | 44.4 | 5 | 55.6 | 0.320 |
- Citation: Solé S, Becerra S, Carvajal C, Bettolli P, Letelier H, Santini A, Vargas L, Cifuentes A, Larsen F, Jara N, Oyarzún J, Bustamante E, Martínez B, Rosenberg D, Galván T. Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial. World J Clin Oncol 2022; 13(10): 813-821
- URL: https://www.wjgnet.com/2218-4333/full/v13/i10/813.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i10.813